| Literature DB >> 30382110 |
Ashish K Sharma1, Stephen H Leppla2, Andrei P Pomerantsev2, Joseph Shiloach3.
Abstract
Protective antigen (PA) of Bacillus anthracis is being considered as a vaccine candidate against anthrax and its production has been explored in several heterologous host systems. Since the systems tested introduced adverse issues such as inclusion body formation and endotoxin contamination, the production from B. anthracis is considered as a preferred method. The present study examines the effect of PA expression on the metabolism of B. anthracis producing strain, BH500, by comparing it with a control strain carrying an empty plasmid. The strains were grown in a bioreactor and RNA-seq analysis of the producing and non-producing strain was conducted. Among the observed differences, the strain expressing rPA had increased transcription of sigL, the gene encoding RNA polymerase σ54, sigB, the general stress transcription factor gene and its regulators rsbW and rsbV, as well as the global regulatory repressor ctsR. There were also decreased expression of intracellular heat stress related genes such as groL, groES, hslO, dnaJ, and dnaK and increased expression of extracellular chaperons csaA and prsA2. Also, major central metabolism genes belonging to TCA, glycolysis, PPP, and amino acids biosynthesis were up-regulated in the PA-producing strain during the lag phase and down-regulated in the log and late-log phases, which was associated with decreased specific growth rates. The information obtained from this study may guide genetic modification of B. anthracis to improve PA production.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30382110 PMCID: PMC6208434 DOI: 10.1038/s41598-018-34196-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Growth and production pattern of Bacillus anthracis expressing PA (pYS5) and the control strain carry plasmid without PA (pSW4); (b) Specific growth rate profile of the expressing (pYS5) and the non-expressing (pSW4) cultures.
Summary of RNA-sequencing reads.
| Batch Run | StrainType | OD600 | Total reads (X 106) | Total unique (X 106) | Unique | Total alignments (X 106) | Aligned | Coverage | Avg. coverage depth |
|---|---|---|---|---|---|---|---|---|---|
| 1 | pSW4 | 3 | 17.77 | 17.28 | 0.97 | 17.35 | 0.97 | 0.62 | 271 |
| 1 | pSW4 | 10 | 17.83 | 17.31 | 0.97 | 17.38 | 0.97 | 0.64 | 267 |
| 1 | pSW4 | 16 | 18.69 | 18.26 | 0.98 | 18.33 | 0.98 | 0.58 | 309 |
| 2 | pSW4 | 3 | 20.97 | 20.38 | 0.97 | 20.47 | 0.97 | 0.66 | 303 |
| 2 | pSW4 | 10 | 18.39 | 17.78 | 0.97 | 17.85 | 0.97 | 0.72 | 243 |
| 2 | pSW4 | 16 | 16.91 | 16.46 | 0.97 | 16.52 | 0.98 | 0.62 | 259 |
| 3 | pSW4 | 3 | 15.48 | 14.96 | 0.97 | 15.01 | 0.97 | 0.68 | 217 |
| 3 | pSW4 | 10 | 28.95 | 27.79 | 0.96 | 27.97 | 0.96 | 0.77 | 354 |
| 3 | pSW4 | 16 | 17.24 | 16.59 | 0.96 | 16.66 | 0.96 | 0.69 | 236 |
| 4 | pYS5 | 3 | 26.93 | 26.18 | 0.97 | 26.34 | 0.98 | 0.75 | 340 |
| 4 | pYS5 | 10 | 20.02 | 19.47 | 0.97 | 19.56 | 0.97 | 0.65 | 292 |
| 4 | pYS5 | 16 | 12.75 | 12.50 | 0.98 | 12.54 | 0.98 | 0.50 | 245 |
| 5 | pYS5 | 3 | 20.46 | 20.07 | 0.98 | 20.17 | 0.98 | 0.65 | 304 |
| 5 | pYS5 | 10 | 17.72 | 17.20 | 0.97 | 17.27 | 0.97 | 0.67 | 252 |
| 5 | pYS5 | 16 | 14.21 | 13.71 | 0.96 | 13.75 | 0.97 | 0.67 | 201 |
| 6 | pYS5 | 3 | 25.60 | 25.05 | 0.98 | 25.20 | 0.98 | 0.70 | 352 |
| 6 | pYS5 | 10 | 17.74 | 17.19 | 0.97 | 17.26 | 0.97 | 0.71 | 238 |
| 6 | pYS5 | 16 | 15.26 | 14.92 | 0.98 | 14.98 | 0.98 | 0.57 | 257 |
Figure 2(a) Principal component analysis (PCA) of triplicates transcriptome data of the 2 stains at three growth phases; (b) Volcano plot representing fold change distribution of gene expressions at i) lag, ii) log and iii) late-log phases between PA producing (pYS5) and non-producing (pSW4) strains. Red and green dots representing up and down-regulated genes respectively.
Figure 3Venn analysis representing the genes commonly up/down-regulated between the 3 growth phases. Genes with list of interest mainly included Lag Phase Vs Log Phase Vs Late-Log Phase i.e. list of genes DE during lag, log, and late-log phase (24); Lag Phase Vs Log Phase i.e. list of genes commonly DE in lag and late-log phases (11); Log Phase Vs Late-Log Phase i.e. list of genes DE during transition from log to late-log phase (6) and Lag Phase Vs Late-Log Phase i.e. list of genes DE in lag phase and later became significant in late-log phase (2).
List of common genes across different phases of batch run in PA expressing and non-expressing control culture. p-value and fold change (log2) values are from a comparison of pYS5 LagPhase vs. pSW4 LagPhase, vice versa for log phase and late-log phase.
| Count No. | Gene name or identifier | Putative Function | Lag phase | Log phase | Late-log phase | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| P-value | Fold change | Status | P-value | Fold change | Status | P-value | Fold change | Status | |||
|
| |||||||||||
| 1 | pyrE | orotate phosphoribosyltransferase | 0.0058 | −3.09 | Down | 0.0007 | −4.07 | Down | 0.0013 | −3.38 | Down |
| 2 | GBAA_3859 | heavy metal-transporting ATPase | 0.0005 | −2.90 | Down | 0.0002 | −3.23 | Down | 0.0006 | −2.79 | Down |
| 3 | uraA | uracil permease | 0.0000 | −4.17 | Down | 0.0000 | −4.07 | Down | 0.0000 | −2.99 | Down |
| 4 | pyrF | orotidine 5′-phosphate decarboxylase | 0.0016 | −3.45 | Down | 0.0004 | −4.10 | Down | 0.0003 | −4.05 | Down |
| 5 | pyrD | dihydroorotate oxidase | 0.0146 | −2.94 | Down | 0.0019 | −3.61 | Down | 0.0122 | −2.49 | Down |
| 6 | GBAA_0239 | hypothetical protein | 0.0000 | −5.22 | Down | 0.0008 | 2.86 | Up | 0.0012 | −2.53 | Down |
| 7 | GBAA_3492 | ABC transporter, efflux permease protein | 0.0000 | −7.08 | Down | 0.0000 | −8.38 | Down | 0.0000 | −7.30 | Down |
| 8 | GBAA_3495 | conserved hypothetical protein | 0.0001 | −3.66 | Down | 0.0003 | −3.07 | Down | 0.0011 | −2.60 | Down |
| 9 | GBAA_4720 | thiJ/pfpI family protein | 0.0001 | −4.14 | Down | 0.0002 | −3.64 | Down | 0.0004 | −3.25 | Down |
| 10 | GBAA_2880 | conserved hypothetical protein | 0.0083 | 3.03 | Up | 0.0019 | 4.64 | Up | 0.0082 | 3.33 | Up |
| 11 | GBAA_4963 | conserved hypothetical protein | 0.0087 | −3.11 | Down | 0.0162 | −2.54 | Down | 0.0139 | −2.65 | Down |
| 12 | pyrC | dihydroorotase | 0.0101 | −2.38 | Down | 0.0003 | −3.36 | Down | 0.0051 | −2.41 | Down |
| 13 | GBAA_2879 | conserved hypothetical protein | 0.0047 | 4.46 | Up | 0.0024 | 6.33 | Up | 0.0198 | 4.01 | Up |
| 14 | nadA | quinolinate synthetase complex, subunit A | 0.0002 | −2.56 | Down | 0.0002 | −2.59 | Down | 0.0010 | −2.09 | Down |
| 15 | GBAA_5564 | conserved hypothetical protein | 0.0296 | −2.03 | Down | 0.0141 | −2.10 | Down | 0.0042 | −2.59 | Down |
| 16 | ctsR | transcriptional regulator CtsR | 0.0364 | 3.39 | Up | 0.0099 | 4.00 | Up | 0.0171 | 4.33 | Up |
| 17 | GBAA_3494 | conserved hypothetical protein | 0.0001 | −3.92 | Down | 0.0003 | −2.99 | Down | 0.0002 | −3.19 | Down |
| 18 | GBAA_1942 | bacterial luciferase family protein | 0.0080 | −3.37 | Down | 0.0010 | −4.36 | Down | 0.0014 | −4.02 | Down |
| 19 | GBAA_0238 | hypothetical protein | 0.0002 | −3.97 | Down | 0.0176 | 2.23 | Up | 0.0062 | −2.37 | Down |
| 20 | GBAA_4962 | transcriptional regulator, ArsR family | 0.0048 | −3.26 | Down | 0.0101 | −2.77 | Down | 0.0040 | −2.86 | Down |
| 21 | katB | catalase | 0.0119 | −3.60 | Down | 0.0474 | −2.52 | Down | 0.0201 | −2.44 | Down |
| 22 | dra | deoxyribose-phosphate aldolase | 0.0029 | −2.55 | Down | 0.0021 | −2.79 | Down | 0.0002 | −3.99 | Down |
| 23 | GBAA_1898 | putative membrane protein | 0.0000 | −6.86 | Down | 0.0002 | −4.62 | Down | 0.0001 | −4.98 | Down |
|
| |||||||||||
| 1 | GBAA_1669 | putative flagellar hook-associated protein | 0.0247 | 2.54 | Up | 0.0121 | 2.50 | Up | 0.8290 | 1.14 | Up |
| 2 | GBAA_2390 | putative ABC transporter, permease protein | 0.0302 | 2.30 | Up | 0.0453 | 2.24 | Up | 0.6881 | 1.10 | Up |
| 3 | GBAA_5712 | yycI protein | 0.0162 | 2.86 | Up | 0.0039 | 3.90 | Up | 0.0673 | 2.68 | Up |
| 4 | GBAA_2878 | conserved hypothetical protein | 0.0198 | 2.30 | Up | 0.0018 | 3.75 | Up | 0.0805 | 2.08 | Up |
| 5 | GBAA_2929 | putative flavoprotein | 0.0417 | 3.23 | Up | 0.0295 | 3.10 | Up | 0.2148 | 2.08 | Up |
| 6 | pckA | phosphoenolpyruvate carboxykinase (ATP) | 0.0088 | −2.08 | Down | 0.0031 | −2.45 | Down | 0.0798 | −1.53 | Down |
| 7 | GBAA_2458 | conserved hypothetical protein | 0.0237 | 5.55 | Up | 0.0031 | 8.69 | Up | 0.1008 | 4.05 | Up |
| 8 | GBAA_5260 | major facilitator family transporter | 0.0061 | −2.90 | Down | 0.0123 | −2.69 | Down | 0.0555 | −1.98 | Down |
| 9 | GBAA_4668 | ABC transporter, permease protein | 0.0248 | 6.12 | Up | 0.0416 | 3.15 | Up | 0.3388 | 1.50 | Up |
| 10 | GBAA_5510 | techoic acid ABC transporter, ATP-binding protein | 0.0420 | 3.00 | Up | 0.0423 | 2.47 | Up | 0.4320 | 1.57 | Up |
| 11 | GBAA_0032 | conserved hypothetical protein | 0.0354 | 2.39 | Up | 0.0491 | 2.24 | Up | 0.1875 | 2.03 | Up |
|
| |||||||||||
| 1 | GBAA_2140 | conserved domain protein | 0.0061 | −2.47 | Down | 0.3184 | −1.35 | Down | 0.0043 | −2.30 | Down |
| 2 | GBAA_4669 | ABC transporter, ATP-binding protein | 0.0416 | 4.04 | Up | 0.0752 | 2.39 | Up | 0.0410 | 2.42 | Up |
|
| |||||||||||
| 1 | GBAA_1162 | alpha-amylase family protein | 0.3857 | 1.39 | Up | 0.0164 | 2.19 | Up | 0.0255 | 2.11 | Up |
| 2 | hemH2 | ferrochelatase | 0.0624 | −2.01 | Down | 0.0173 | −2.36 | Down | 0.0069 | −2.41 | Down |
| 3 | carB | carbamoyl-phosphate synthase, large subunit | 0.0933 | −2.03 | Down | 0.0017 | −3.38 | Down | 0.0076 | −2.57 | Down |
| 4 | GBAA_2459 | hypothetical protein | 0.0690 | 1.74 | Up | 0.0057 | 2.38 | Up | 0.0414 | 2.02 | Up |
| 5 | sigB | RNA polymerase sigma-B factor | 0.0455 | 1.72 | Up | 0.0070 | 2.21 | Up | 0.0220 | 2.04 | Up |
| 6 | GBAA_4072 | conserved domain protein | 0.0601 | 2.92 | Up | 0.0048 | 4.42 | Up | 0.0337 | 3.80 | Up |
Figure 4Pathway enrichment analysis of DE gene list from (a) lag phase, (b) log phase, (c) late-log phase, and (d) Change in enrichment scores of pathways in lag, log, and late-log phase. (a–c) Number of over-represented genes is mentioned in front of the pathway name, along with the enrichment score on top of each bar. (d)- same number of pathways in each bar showing enrichment scores of pathways as their relative thickness on Y-axis).
Figure 5log2 fold change values of genes in the energy metabolism pathways (a) Glycolysis, (b) TCA, (c) PPP, (d) Overall gene expression distribution in Glycolysis, TCA and PPP. The large dot represents the average (mean) of all data values for subsystem genes belonging to a pathway while small dots represent a data value for an individual subsystem/gene) (generated using EcoCyc omics dashboard). Blue color represent lag phase (pYS5) vs lag phase (pSW4), orange color represent log phase (pYS5) vs log phase (pSW4) and gold color represents late-log phase (pYS5) vs late-log phase (pSW4).
Figure 6Gene expression profile of amino acid metabolism (a) log2 fold change of each amino acid gene in PA expressing compared to control, (b) Overall gene expression distribution of AA biosynthesis in lag, log, and late-log phases. Large dot represents the average (mean) of all data while small dots represents a data value for an individual gene (using EcoCyc omics dashboard).
Figure 7Heatmap of fold-change gene expression values of the heat shock genes, chaperones and DE regulators. FC represents ‘fold change’; PA represents ‘protective antigen producing strain’ and NP represents ‘non-producing strain’.
Figure 8Schematic representation of major pathways significantly affected in the rPA expressing B. anthracis.